Principal Scientist visa sponsorship salary
Across 91 certified work-visa filings, the median wage for Principal Scientist is $135,000. The middle half of filings fall between $111,374 and $157,063, and the top decile begins at $172,100. Classified under SOC 19-1042.00 (Medical Scientists, Except Epidemiologists).
Median
$135,000
25th pct
$111,374
75th pct
$157,063
90th pct
$172,100
Filings
91
$68,000$214,240
Who pays what for Principal Scientist
Ranked by number of certified filings
| Employer | Filings | 25th | Median | 75th |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 12 | $152,975 | $155,376 | $162,804 |
| Bristol-Myers Squibb Company | 6 | $146,939 | $154,088 | $159,901 |
| Eli Lilly and Company | 6 | $116,933 | $119,110 | $120,228 |
| Pfizer INC. | 6 | $102,900 | $105,000 | $107,099 |
| Calder Biosciences Inc. | 2 | $153,001 | $153,002 | $153,004 |
| Zoetis, Inc. | 2 | $129,000 | $133,000 | $137,000 |
| Sanofi US Services Inc. | 2 | $125,753 | $129,256 | $132,758 |
| Pharmavite LLC | 2 | $115,250 | $124,500 | $133,750 |
| BrickBio Inc. | 2 | $114,317 | $118,415 | $122,512 |
| ElectraTect, Inc. | 2 | $112,237 | $112,237 | $112,237 |
| Riconpharma, LLC | 2 | $109,750 | $111,500 | $113,250 |
| American Cancer Society, INC. | 2 | $110,510 | $110,510 | $110,510 |
| GlaxoSmithKline LLC | 2 | $98,813 | $100,125 | $101,438 |
| JangoBio LLC | 2 | $70,209 | $72,418 | $74,626 |
Individual filings
Most recent certified determinations
| Employer | Location | Wage | Level | Decided |
|---|---|---|---|---|
| Repertoire Immune Medicines, Inc. | Cambridge, MA | $180,000 | IV | Sep 24, 2025 |
| Riconpharma, LLC | Denville, NJ | $115,000 | III | Sep 24, 2025 |
| Eli Lilly and Company | Boston, MA | $130,000 | III | Sep 17, 2025 |
| American Cancer Society, INC. | Houston, TX | $110,510 | III | Sep 12, 2025 |
| Yemaya, Inc. | Palo Alto, CA | $190,000 | III | Aug 29, 2025 |
| American Cancer Society, INC. | Houston, TX | $110,510 | III | Aug 7, 2025 |
| Merck Sharp & Dohme LLC | Rahway, NJ | $187,000 | IV | Aug 6, 2025 |
| Tulex Pharmaceuticals Inc. | Cranbury, NJ | $115,000 | IV | Aug 5, 2025 |
| Bristol-Myers Squibb Company | Princeton, NJ | $159,984 | III | Aug 4, 2025 |
| Eli Lilly and Company | Branchburg, NJ | $119,110 | III | Aug 4, 2025 |
| Eli Lilly and Company | New York, NY | $120,600 | III | Jul 28, 2025 |
| Adare Pharmaceuticals Inc. | Philadelphia, PA | $115,000 | IV | Jul 23, 2025 |
| Nobell Foods, Inc. | South San Francisco,, CA | $125,466 | IV | Jul 21, 2025 |
| Eli Lilly and Company | Branchburg, IN | $119,110 | III | Jul 18, 2025 |
| Regeneron Pharmaceuticals, Inc. | Tarrytown, NY | $172,500 | IV | Jul 16, 2025 |
| TCG GreenChem, Inc | Ewing, NJ | $103,967 | III | Jul 16, 2025 |
| Cyprotex US LLC | Framingham, MA | $169,289 | IV | Jul 14, 2025 |
| Eli Lilly and Company | New York, NY | $116,207 | III | Jul 7, 2025 |
| Sanofi US Services Inc. | Cambridge, MA | $136,261 | IV | Jul 7, 2025 |
| Eli Lilly and Company | New York, NY | $116,207 | III | Jul 3, 2025 |
| ElectraTect, Inc. | Phoenix, AZ | $112,237 | III | Jun 24, 2025 |
| The Children's Hospital of Philadelphia | Philadelphia, PA | $72,238 | II | Jun 20, 2025 |
| Boehringer Ingelheim Pharmaceuticals, INC. | Ridgefield, CT | $183,475 | IV | Jun 20, 2025 |
| Pfizer INC. | Somerset, NJ | $102,900 | II | Jun 18, 2025 |
| Pfizer INC. | Andover, MA | $127,000 | III | Jun 18, 2025 |
Prevailing wage levels I through IV reflect the experience and responsibility the employer attested to, not seniority titles. A level I filing is an entry-level determination; level IV is fully competent and independent. Comparing across levels explains much of the spread between the 25th and 90th percentile above.